|Videos|April 13, 2021
Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Clinical Pearls for CIDP Management
May 29th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Expanding the Alzheimer Drug Development Pipeline
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
Shared Decision-Making and Ethics in Complex Neurology Clinical Research: Paul Ford, PhD
5